MSAM
EDIT icon

Moloney Securities Asset Management’s Editas Medicine EDIT Stock Holding History

Moloney Securities Asset Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-13,285
Closed -$319K – 279
2017
Q3 		$319K Buy
+13,285
New +$253K 0.14% 181

Other funds holding EDIT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

Moloney Securities Asset Management's EDIT Position: Q4 2017 in Review

Moloney Securities Asset Management sold out of Editas Medicine (EDIT) in Q4 2017, closing a stake of 13,285 shares — an estimated $319K sold.

Moloney Securities Asset Management first reported a position in EDIT in Q3 2017 and held it in 1 quarter. The position peaked at $319K in Q3 2017. 151 funds tracked by Wall St. Rank hold EDIT as of Q4 2017.

  • Moloney Securities Asset Management reported no remaining Editas Medicine position as of Q4 2017 after selling out during the quarter.
  • Moloney Securities Asset Management sold 13,285 Editas Medicine shares in Q4 2017, an estimated $319K.
  • Moloney Securities Asset Management first reported a position in Editas Medicine in Q3 2017 and held it in 1 quarter.
  • Moloney Securities Asset Management's Editas Medicine position peaked at $319K in Q3 2017.
  • 151 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2017.

Based on Moloney Securities Asset Management's 13F filing for Q4 2017, filed 25 Jan 2018.